Why Nutriband Inc.’s (NTRB) Stock Is Down 5.21%
As of Wednesday, September 30, Nutriband Inc.’s NTRB share price has dipped by 5.21%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Commentary & Analysis
Why Nutriband Inc.’s (NTRB) Stock Is Up 10.88%
As of Monday, September 28, Nutriband Inc.’s NTRB share price has surged by 10.88%, which has investors questioning if this is right time to sell.Michael Rose
Why Nutriband Inc.’s (NTRB) Stock Is Down 6.84%
As of Friday, September 25, Nutriband Inc.’s NTRB share price has dipped by 6.84%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Nutriband Inc.’s (NTRB) Stock Is Down 14.13%
As of Friday, September 25, Nutriband Inc.’s NTRB share price has dipped by 14.13%, which has investors questioning if this is right time to buy.Tudor Pop
Why Nutriband Inc.’s (NTRB) Stock Is Up 6.73%
As of Thursday, September 24, Nutriband Inc.’s NTRB share price has surged by 6.73%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | NTRB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $91.4 | $560.7 | 21% |
|
| Shares Out (Mil) | 12.2 | 42.3 | 23% |
|
| Institutional Ownership | 6.5% | 84.3% | 6% |
|
| Float (Mil) | 5.3 | 45.7 | 13% |
|
| Beta | 2.04 | 0.72 | 92% |
|
| Avg Daily Volume (000s) | 217 | 392 | 44% |
|
| Price Change (52-week) |
6.5% | 60.8% | 58% |
|
| Growth | NTRB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 17.3% | 5.7% | 77% |
|
| Net Income (5yr) | (23.1%) | (1.5%) | 18% |
|
| EPS (5yr) | (42.7%) | 15.1% | 5 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 0.0% | (15.1%) | 64% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | NTRB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2 | $326 | 3% |
|
| Net Income (TTM) (Mil) | ($7) | ($11) | 31% |
|
| EPS (TTM) | ($0.574) | ($0.700) | 26% |
|
| Operating Cash Flow (TTM) (Mil) | ($4) | ($7) | 27% |
|
| Net Cash Flow (TTM) (Mil) | na | $6 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $6 | 10% |
|
| Enterprise Value (Q1) (Mil) | $69 | $493 | 18% |
|
| Valuation | NTRB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 17.09 | 2.34 | 95% |
|
| P/E | na | 17.3 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | NTRB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 33.1% | 69.4% | 39% |
|
| Net Margin | (430.4%) | 2.5% | 2% |
|
| ROA | (84.6%) | (22.4%) | 7% |
|
| ROE | (100.8%) | (23.8%) | 9% |
|
| Liabilities to Assets | 15.3% | 32.6% | 10% |
|
| F-Score | 2 | 3 | 7% |
|
Nutriband Inc. did not pass any screens on 9/30/2026.
